Trial intelligence / Profile preview

Human Model of S. Paratyphi A Challenge in Healthy Adults

NCT02100397Completed

Sponsor
University of Oxford
Start
Mar 2014
Primary completion
Jan 2016
Modality
Biologic
Countries
1
01

Overview

Open-label, single-arm trial of Salmonella Paratyphi A (NVGH 308) in enteric fever, sponsored by University of Oxford. Primary endpoint: Clinical or microbiologically proven paratyphoid infection at 14 days. Started Mar 2014; status: completed.

02

Drugs

Salmonella Paratyphi A (NVGH 308)
03

Conditions

enteric fever

Beyond the preview

Go deeper on NCT02100397.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02100397.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call